Top 20 Life Sciences Deals of 2024 by Total Deal Value 

By Ani Harutyunyan

Feb 20, 2025

Media Coverage

Using DealForma insights, PharmaShots highlights the Top 20 Life Sciences deals of 2024, led by Arrowhead–Sarepta’s $11.37B licensing agreement. Read it here

DealForma Research

Biopharma Therapeutics and Platforms M&A – 2025 Review

March 9, 2026

Biopharma Therapeutics and Platforms R&D Partnerships – 2025 Review

February 26, 2026

Dermatology M&A – 2024-2025 Review

February 23, 2026

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures